MedPlus Health Services to Buy Back Shares Worth ₹130 Crores via Open Market at Up to ₹750 per Share
Buyback excludes promoters and persons in control, opens on November 13, 2026, following board approval and public announcement
MedPlus Health Services Limited has approved a buyback of fully paid equity shares through the open market route for up to ₹130 crores at a maximum price of ₹750 per share. The buyback excludes promoters and persons in control and will commence on November 13, 2026, complying with SEBI regulations.
MedPlus Health Services Limited
Corporate Action
MedPlus Health Services Limited announced a buyback of its fully paid equity shares through the open market route, capped at ₹130 crores with a maximum price of ₹750 per equity share. The buyback excludes promoters and persons in control and begins on November 13, 2026.
The board approved the buyback on November 6, 2026, authorizing share repurchase up to 9.87% of the company's paid-up equity share capital based on standalone financials as of March 31, 2026. The buyback will be conducted through stock exchanges using a mechanism compliant with SEBI's Buy-Back of Securities Regulations, 2018.
The repurchase excludes shares held by promoters and persons in control. The maximum buyback price per share is fixed at ₹750, with the total buyback size capped at ₹130 crores excluding transaction costs such as brokerage, taxes, and related expenses.
The buyback period will open within four working days of the public announcement and will close within 66 working days from opening. The company may close the buyback early upon utilizing at least 75% of the maximum buyback size.
The public announcement was made on November 9, 2026, in major newspapers including Financial Express (English), Jansatta (Hindi), and Nava Telangana (Telugu). The announcement and related documents are also available on the websites of MedPlus, Nuvama Wealth Management Limited (manager to the buyback), and the NSE and BSE.
Highlights
- Board approved buyback on November 6, 2026.
- Buyback amount capped at ₹130 crores excluding transaction costs.
- Maximum buyback price set at ₹750 per equity share (face value ₹2 each).
- Buyback excludes promoters and persons in control.
- Buyback opens November 13, 2026, for up to 66 working days.
- Repurchase up to 9.87% of paid-up equity share capital (standalone basis).
Key Data Snapshot
What happened
- MedPlus Health Services approved an open market buyback of fully paid equity shares.
- Buyback excludes promoters and persons in control, targeting other shareholders.
- The buyback aims to repurchase shares worth up to ₹130 crores at a maximum price of ₹750 per share.
- The face value of each equity share is ₹2.
- Buyback to use stock exchange mechanism as per SEBI regulations.
Key details
- Board approved the buyback resolution on November 6, 2026.
- Buyback will commence within four working days after the public announcement dated November 9, 2026.
- Buyback period may close early if at least 75% utilization of the buyback size is met.
- Transaction costs are excluded from the maximum buyback size.
- Public announcement published in English, Hindi, and Telugu newspapers covering key regions.
Regulatory and governance context
- Buyback complies with Companies Act, 2013, SEBI Buy-Back of Securities Regulations, 2018, and SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- Approvals and compliances from SEBI, ROC Telangana, BSE and NSE are part of the process.
- Buyback executed through open market mechanism on stock exchanges having nationwide trading terminals.
Next milestones
- Buyback period to start on November 13, 2026.
- Will remain open up to 66 working days unless closed earlier by the Board.
- Further notices about buyback closing and completion will follow as per regulatory requirements.
Highlights
- Board approved buyback on November 6, 2026.
- Buyback amount capped at ₹130 crores excluding transaction costs.
- Maximum buyback price set at ₹750 per equity share (face value ₹2 each).
- Buyback excludes promoters and persons in control.
- Buyback opens November 13, 2026, for up to 66 working days.
- Repurchase up to 9.87% of paid-up equity share capital (standalone basis).
Disclosures
- Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018
- Companies Act, 2013 and Companies (Share Capital and Debentures) Rules, 2014
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Promoters and persons in control are excluded from participating in the buyback.
More News on Corporate Action
View allLatest corporate announcements and market updates in Corporate Action.
String Metaverse Limited Grants 5 Crore Employee Stock Options at ₹8 Each Under 2023 Scheme
String Metaverse Limited has approved the grant of 5 crore employee stock options under its Employee Stock Option Scheme 2023, aimed at eligible employees of the company and its subsidiaries.
Read Full StoryUGRO Capital Allots INR 105 Crore Secured Non-Convertible Debentures at 9.75% Coupon
UGRO Capital Limited allotted 1,05,000 senior, secured non-convertible debentures totaling INR 105 crore on 19th November 2026 through private placement, carrying a coupon rate of 9.75% per annum payable monthly.
Read Full StoryTech Mahindra Allots 1,90,000 Equity Shares to ESOP Trust for Performance Share Plan 2025
Tech Mahindra Ltd has allotted 1,90,000 fully-paid equity shares of ₹5 each to its ESOP Trust to facilitate the Tech Mahindra Performance Share Plan 2025.
Read Full Story